Nephrotic syndrome.

Area of Science:

• Pediatric Nephrology
• Clinical Therapeutics

Background:

• Minimal change disease is the most frequent cause of nephrotic syndrome in school-aged children.
• Nephrotic syndrome management involves addressing potential complications like dyslipidemia, infection, and thrombosis.

Purpose of the Study:

• To outline the current understanding and management strategies for nephrotic syndrome in children.
• To review the role of corticosteroids and alternative therapies in treating nephrotic syndrome.

Main Methods:

• Review of observational studies and consensus guidelines.
• Synthesis of research evidence and expert opinion on treatment protocols and complication management.

Main Results:

• Corticosteroids, particularly prednisone, are the established first-line therapy with specific dosing recommendations.
• Alternative therapies show variable efficacy for corticosteroid-dependent or resistant nephrotic syndrome, requiring careful consideration of adverse effects.
• Nephrotic syndrome often follows a relapsing-remitting course.

Conclusions:

• Corticosteroid therapy is the cornerstone for treating childhood nephrotic syndrome.
• Management requires vigilance for complications and judicious use of alternative agents.
• Understanding the disease's relapsing nature is crucial for long-term care.